Today: 20 May 2026
Experian PLC stock rises after Ascend data move, with dividend and Q3 update in view
7 January 2026
1 min read

Experian PLC stock rises after Ascend data move, with dividend and Q3 update in view

London, January 7, 2026, 08:17 GMT — Regular session

  • Shares up 0.6% early in London trade after a new Ascend platform data rollout
  • Experian says lenders can now tap its UK commercial credit data inside Ascend
  • Next catalysts include Thursday’s ex-dividend date and a Jan. 21 trading update

Experian (EXPN.L) shares rose 0.6% to 3,405 pence by 0802 GMT on Wednesday, after the credit data firm rolled out a new data capability for lenders earlier this week.

On Monday, Experian said its commercial data — covering the borrowing and repayment history of more than eight million UK businesses — is now available via its cloud-based Ascend analytics and decisioning platform. David Gallihawk, chief product officer for Experian’s UK and Ireland business information unit, said: “Clients can have an even better view of their customers and businesses so they can make smarter, faster decisions.” experianplc.com

The timing matters because investors have several near-term triggers to trade around, including the stock’s first interim ex-dividend date on Jan. 8 and a third-quarter trading update due on Jan. 21. Experian’s investor calendar also flags an exchange-rate setting date for the interim dividend on Jan. 16 and payment on Feb. 6, with full-year results scheduled for May 20.

The move came as London shares digested a rally that pushed the FTSE 100 above the 10,000 mark on Tuesday, driven by energy and defence stocks after U.S. military action in Venezuela raised worries over crude supply.

For income-focused investors, Experian’s website shows a first interim dividend of 21.25 U.S. cents per share, payable on Feb. 6 to shareholders on the register at the close of business on Jan. 9. It said shareholders have until Jan. 9 to elect to receive U.S. dollars, otherwise dividends will be paid in sterling using the exchange rate determined on Jan. 16.

The stock ended Tuesday at 3,384 pence, down 1.25%, after a 2.85% gain on Monday. The shares have traded between 3,049 and 4,101 pence over the last 52 weeks, leaving them about 17% below the high and keeping the 3,400 level in focus in early 2026 dealing.

But the product launch will matter to investors only if it feeds through into contract wins and usage, and that is harder to judge in a choppy lending backdrop. A slowdown in business borrowing or tighter credit conditions can curb demand for credit data and decision tools, even when new features land on schedule.

Next up is Thursday’s ex-dividend date, followed by Experian’s Jan. 21 third-quarter trading update for clearer signals on demand from lenders and uptake of its Ascend platform.

Stock Market Today

  • Williams-Sonoma Gains 1.58% as Market Declines, Eyes Upcoming Earnings
    May 19, 2026, 7:31 PM EDT. Williams-Sonoma (WSM) shares rose 1.58% to $171.83, outperforming the S&P 500's 0.67% drop. The stock had declined 16.27% over the past month, lagging the sector's 0.69% loss but behind the S&P 500's 4% gain. Investors await WSM's upcoming earnings report, expected to show $1.80 per share in EPS, down 2.7% year-over-year, with revenue projected to rise 4.25% to $1.8 billion. The company's full-year estimates anticipate 4.75% EPS growth and 4.39% revenue growth. Analyst estimate revisions have nudged EPS projections higher by 0.58% in 30 days, with WSM holding a Zacks Rank #3 (Hold). Valuation indicators show a Forward P/E of 18.27, slightly below industry average, while the PEG ratio of 2.12 exceeds the Retail - Home Furnishings sector average of 1.63.

Latest articles

James Hardie Drops After Warning on Housing, Even With Q4 Beat

James Hardie Drops After Warning on Housing, Even With Q4 Beat

20 May 2026
James Hardie’s U.S.-listed shares dropped 6.1% Tuesday and slid another 2.6% after hours after reporting a 35% fall in quarterly net income to $28.5 million, despite a 45% jump in net sales to $1.40 billion. The company cited weak housing demand and warned the market remains uncertain. ASX shares had not traded post-earnings; they last closed at A$26.78, up 2.9%.
SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

20 May 2026
SELLAS Life Sciences shares rose 4.1% to $7.59 Tuesday after CEO Angelos Stergiou said its Phase 3 AML trial is two events from final analysis. The company reported $107.1 million in cash and a first-quarter net loss of $8.4 million. The REGAL trial’s main measure is overall survival. SELLAS remains blinded to results until the 80th event triggers data review.
Red Robin Shares Rise After Earnings Beat

Red Robin Shares Rise After Earnings Beat

20 May 2026
Red Robin shares surged 15.6% after hours to $4.45 Tuesday, following first-quarter revenue of $378.3 million that beat Wall Street estimates despite a 0.6% drop in comparable sales and a 1.6% decline in guest traffic. Net loss was $2.2 million, or 12 cents per share. The company reaffirmed its 2026 outlook and said refranchising talks are in final stages.
Cipla share price slides after USFDA flags Pharmathen: what the Form 483 says
Previous Story

Cipla share price slides after USFDA flags Pharmathen: what the Form 483 says

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings
Next Story

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

Go toTop